UniProt ID | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
---|---|---|---|---|---|
U3CA32 | N-acetylgalactosamine-6-sulfatase |
|
2 | 0 |
|
P51500 | Choriogonadotropin subunit beta |
|
4 | 0 |
|
F7DLH5 | GDNF family receptor alpha-1 |
|
2 | 0 |
|
F7I399 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
U3BMC6 | Fibroblast growth factor receptor |
|
8 | 0 |
|
U3CW50 | A disintegrin and metalloproteinase with thrombospondin motifs 1 preproprotein |
|
3 | 0 |
|
F7AZG3 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
U3FD32 | A disintegrin and metalloproteinase with thrombospondin motifs 1 preproprotein |
|
3 | 0 |
|
A0A8I3WNI8 | Paraoxonase |
|
2 | 0 |
|
F6VKK1 | Tartrate-resistant acid phosphatase type 5 |
|
1 | 0 |
|
F6X7H6 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
F7FC05 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
F6RG56 | Mucolipin-3 |
|
2 | 0 |
|
F7HYH8 | Peptidylglycine alpha-amidating monooxygenase |
|
1 | 0 |
|
A0A8I3W6Z2 | Paraoxonase |
|
3 | 0 |
|
U3BAC2 | P2X purinoceptor |
|
1 | 0 |
|
A0A5F4WLM1 | Voltage-dependent P/Q-type calcium channel subunit alpha |
|
1 | 0 |
|
U3DBF8 | Phosphoinositide phospholipase C |
|
2 | 0 |
|
F7CNJ6 | Angiotensin-converting enzyme |
|
4 | 0 |
|
Q2QLG5 | Hepatocyte growth factor receptor |
|
13 | 0 |
|
U3F5T2 | Cathepsin D |
|
2 | 0 |
|
A0A8I4A237 | Phosphoinositide phospholipase C |
|
2 | 0 |
|
F6WKW8 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A5F4W8V1 | Voltage-dependent P/Q-type calcium channel subunit alpha |
|
1 | 0 |
|
U3BD05 | Potassium channel subfamily K member |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025